Manufacturers/Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc.

19 drugs in NADAC|17 Generic,2 Brand

Amphastar Pharmaceuticals, Inc. lists 19 NDCs in the CMS NADAC file (17 generic, 2 brand), at an average NADAC of $78.99 per unit, with a week-over-week move of -3.2% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.

Total Drugs

17G / 2B

Avg Price / Unit

$78.9863

$6.45 – $479.95

Avg 7d Change

-3.21%

Across 12 drugs with changes

7d Activity

1↑11↓7 flat

of 19 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Lead market

Enoxaparin sodium market

See the molecule this manufacturer shows up in most often and compare it against competing suppliers.

Lead class

Low Molecular Weight Heparin therapeutic class

Review the broader class where Amphastar Pharmaceuticals, Inc. has the strongest current portfolio footprint.

Trend hub

Portfolio trend view

Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.

Guide

NADAC pricing primer

Use the explainer for context on the benchmark this manufacturer is being compared against.

Frequently Asked Questions

How many drugs does Amphastar Pharmaceuticals, Inc. make?

Amphastar Pharmaceuticals, Inc. lists 19 NDCs in the CMS NADAC file — 17 generic and 2 brand products.

What is the average price of Amphastar Pharmaceuticals, Inc. drugs?

The average NADAC across Amphastar Pharmaceuticals, Inc.'s portfolio is $78.9863 per unit, ranging from $6.4517 to $479.9511.

What types of drugs does Amphastar Pharmaceuticals, Inc. make?

Amphastar Pharmaceuticals, Inc. makes drugs across 6 FDA pharmacologic classes. The most common by NDC count are Low Molecular Weight Heparin (8), Progestin (6), Antihypoglycemic Agent (2), Gastrointestinal Motility Inhibitor (2), Parathyroid Hormone Analog (1).

Has Amphastar Pharmaceuticals, Inc. had any drug recalls?

1 FDA recall is matched to Amphastar Pharmaceuticals, Inc. in the openFDA feed, most recently on Aug 15, 2017.

How has Amphastar Pharmaceuticals, Inc.'s pricing changed recently?

Over the past 7 days, 1 Amphastar Pharmaceuticals, Inc. product rose and 11 fell, with a portfolio-wide average change of -3.2%.

Drug Portfolio

19 drugs total, 19 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Therapeutic Class
TERIPARATIDE 560 MCG/2.24 ML PEN Teriparatide	00548231100	$479.9511 per ML	-3.00%	Generic	—	Parathyroid Hormone Analog
BAQSIMI 3 MG SPRAY TWO PACK glucagon	00548835202	$293.0352 per EA	—	Brand	—	Antihypoglycemic Agent, Gastrointestinal Motility Inhibitor
BAQSIMI 3 MG SPRAY ONE PACK glucagon	00548835101	$292.9801 per EA	—	Brand	—	Antihypoglycemic Agent, Gastrointestinal Motility Inhibitor
GLUCAGON 1 MG EMERGENCY KIT Glucagon	00548585000	$154.2034 per EA	-3.94%	Generic	—	—
GANIRELIX ACET 250 MCG/0.5 ML Ganirelix Acetate	00548500100	$62.3467 per ML	—	Generic	—	Gonadotropin Releasing Hormone Receptor Antagonist
MEDROXYPROGESTERONE 150 MG/ML Medroxyprogesterone acetate	00548571100	$34.5253 per ML	—	Generic	—	Progestin
MEDROXYPROGESTERONE 150 MG/ML Medroxyprogesterone acetate	00548570100	$27.3638 per ML	-3.96%	Generic	—	Progestin
MEDROXYPROGESTERONE 150 MG/ML Medroxyprogesterone acetate	00548541025	$24.8668 per ML	—	Generic	—	Progestin
MEDROXYPROGESTERONE 150 MG/ML Medroxyprogesterone acetate	00548541000	$23.0735 per ML	—	Generic	—	Progestin
MEDROXYPROGESTERONE 150 MG/ML Medroxyprogesterone acetate	00548540025	$22.8495 per ML	—	Generic	—	Progestin
MEDROXYPROGESTERONE 150 MG/ML Medroxyprogesterone acetate	00548540000	$18.8535 per ML	+2.95%	Generic	—	Progestin
ENOXAPARIN 120 MG/0.8 ML SYR Enoxaparin sodium	00548560600	$10.4173 per ML	-4.36%	Generic	—	Low Molecular Weight Heparin
ENOXAPARIN 300 MG/3 ML VIAL enoxaparin sodium	00548560800	$9.8724 per ML	-3.84%	Generic	—	Low Molecular Weight Heparin
ENOXAPARIN 30 MG/0.3 ML SYR Enoxaparin sodium	00548560100	$9.1268 per ML	-4.83%	Generic	—	Low Molecular Weight Heparin
ENOXAPARIN 150 MG/ML SYRINGE Enoxaparin sodium	00548560700	$8.9038 per ML	-7.60%	Generic	—	Low Molecular Weight Heparin
ENOXAPARIN 40 MG/0.4 ML SYR Enoxaparin sodium	00548560200	$7.7791 per ML	-4.26%	Generic	—	Low Molecular Weight Heparin
ENOXAPARIN 60 MG/0.6 ML SYR Enoxaparin sodium	00548560300	$7.4522 per ML	-2.23%	Generic	—	Low Molecular Weight Heparin
ENOXAPARIN 80 MG/0.8 ML SYR Enoxaparin sodium	00548560400	$6.6868 per ML	-1.27%	Generic	—	Low Molecular Weight Heparin
ENOXAPARIN 100 MG/ML SYRINGE Enoxaparin sodium	00548560500	$6.4517 per ML	-2.15%	Generic	—	Low Molecular Weight Heparin

FDA Recalls (1)

Recalls matched by company name. Verify current status with FDA.

D-1124-2017 →

Terminated

Class II

Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL single-dose vials, Rx only, Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA 91730, NDC 0548-9021-00

Crystallization: Particulate matter (Ketorolac Calcium Salt) was observed from several lots of retained samples.

Initiated: 8/15/2017